28th Annual Healthcare Conference

Investors will have the opportunity to hear and meet with over 100 company management teams in 1-on-1 and small group meetings. We anticipate that this will, once again, be one of the most important investor conferences in this sector. Throughout the conference, investors will have access to, and be able gain insight from key thought leaders as the companies will address topical issues such as health reform implementation; Medicare and Medicaid policy changes; generic drug regulation; development of new blockbuster pharmaceutical and biotechnology products; product safety and patent issues; evolving payment models; Food and Drug Administration policy; managed care; emerging market opportunities and the current M&A environment.